WEBULL
News
MTHRF
12.91
NaN%
--
Jefferies Sticks to Their Hold Rating for M3 (MTHRF)
TipRanks · 03/06 10:35
Daiwa Keeps Their Buy Rating on M3 (MTHRF)
TipRanks · 03/04 10:57
M3 Advances Share Buyback, Acquires 5.8 Million Shares in February
TipRanks · 03/02 06:59
Morgan Stanley Reaffirms Their Buy Rating on M3 (MTHRF)
TipRanks · 02/24 10:47
Mizuho Securities Keeps Their Hold Rating on M3 (MTHRF)
TipRanks · 02/17 10:57
UBS Reaffirms Their Buy Rating on M3 (MTHRF)
TipRanks · 02/10 10:07
Analysts Offer Insights on Healthcare Companies: Vir Biotechnology (VIR), M3 (OtherMTHRF) and Sarepta Therapeutics (SRPT)
TipRanks · 02/09 11:40
Analysts Conflicted on These Healthcare Names: Denali Therapeutics (DNLI), M3 (OtherMTHRF) and Doximity (DOCS)
TipRanks · 02/06 10:40
Tokai-Tokyo Securities Reaffirms Their Buy Rating on M3 (MTHRF)
TipRanks · 02/06 10:36
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Arcellx Inc (ACLX), Align Tech (ALGN) and M3 (OtherMTHRF)
TipRanks · 02/05 10:50
M3 Builds Momentum With Double-Digit Profit Growth, Sticks to FY2026 Outlook
TipRanks · 02/04 06:58
M3 Reports Progress on Ongoing ¥20 Billion Share Buyback Program
TipRanks · 02/02 07:00
Bank of America Securities Sticks to Its Buy Rating for M3 (MTHRF)
TipRanks · 01/28 14:17
M3 (MTHRF) Price Target Increased by 23.01% to 18.55
NASDAQ · 01/14 01:18
M3 Continues Share Buyback, Uses Fraction of ¥20 Billion Authorization
TipRanks · 01/05 06:57
M3 Introduces Long-Term Stock Option Incentives to Align Employee and Shareholder Interests
TipRanks · 12/26/2025 06:57
M3, Inc. Announces Share Repurchase Update
TipRanks · 12/01/2025 06:59
M3, Inc. Reports Strong First Half 2025 Growth
TipRanks · 11/13/2025 03:56
M3, Inc. Updates on Share Repurchase Program
TipRanks · 11/12/2025 07:02
Analysts Offer Insights on Healthcare Companies: Protara Therapeutics (TARA), Kura Oncology (KURA) and M3 (OtherMTHRF)
Barchart · 10/10/2025 05:36
More
Webull provides a variety of real-time MTHRF stock news. You can receive the latest news about M3 Inc through multiple platforms. This information may help you make smarter investment decisions.
About MTHRF
M3 Inc is a Japan-based company mainly engaged in the provision of services centering on the platform of healthcare. The Company has five business segments. Medical Platforms segment conducts marketing-related businesses in Japan utilizing the Internet and real operations centered on medical employee specialized site m3.com. Evidence Solution segment is engaged in the contract research organization (CRO) business that supports clinical development work and research, and site management organization (SMO) business that manages the clinical trial operations. Career Solutions segment is engaged in human resource services for healthcare professionals. Site Solution segment provides operational support for medical institutions and home-visit nursing services. Overseas segment provides services of medical related marketing support, research and careers, utilizing the medical employee specialized sites in the United States, the United Kingdom, China, Korea, India, France, Germany and Spain.